A Disciplined Approach to Healthcare Value Creation
We invest with conviction across twelve healthcare sectors, partnering with exceptional management teams to build category-defining companies with lasting impact.
What We Look For
Every investment we make is evaluated against a rigorous set of criteria designed to identify companies with durable competitive advantages and significant growth potential.
Differentiated Technology or Service
We seek companies with proprietary technology, unique clinical capabilities, or service models that are difficult to replicate and create meaningful barriers to entry.
Proven Leadership Teams
We back operators and founders with deep domain expertise, a track record of execution, and the vision to build enduring enterprises in complex healthcare markets.
Large Addressable Markets
Our portfolio targets sectors with significant and growing total addressable markets, driven by demographic trends, regulatory tailwinds, and structural shifts in care delivery.
Clear Path to Profitability
We prioritize companies with sustainable unit economics, identifiable paths to profitability, and capital-efficient growth models that do not rely on perpetual external funding.
Regulatory & Compliance Strength
Healthcare demands rigorous compliance. We invest in companies with strong regulatory foundations, quality management systems, and proactive approaches to evolving standards.
Scalable Infrastructure
We look for businesses with the operational infrastructure — technology platforms, supply chains, and talent pipelines — to scale efficiently without proportional cost increases.
Where We Invest
Growth Equity
Partnering with proven businesses ready to accelerate — expanding geographies, adding service lines, or scaling technology platforms across the healthcare continuum.
Buyout
Acquiring established healthcare businesses with strong fundamentals, then driving operational improvements, strategic add-ons, and management enhancements to unlock value.
Venture & Clinical Stage
Selectively backing early-stage pharmaceutical, biotech, and medical device companies with breakthrough science and clear regulatory pathways to commercialization.
The Convergence Opportunity
We believe the next decade will produce the most significant value creation opportunity in the history of healthcare. The convergence of advanced manufacturing, pharmaceutical innovation, digital health infrastructure, and shifting care delivery models is creating a structural transformation that rewards investors with deep sector expertise and long-term conviction. Titanium Healthcare is positioned at the center of this convergence.
Ready to Explore a Partnership?
We welcome conversations with founders, operators, and institutions building the future of healthcare.
Get in Touch